| Literature DB >> 27918436 |
Rodolfo Abarca-Vargas1, Carlos F Peña Malacara2, Vera L Petricevich3.
Abstract
Bougainvillea is widely used in traditional Mexican medicine to treat several diseases. This study was designed to characterize the chemical constituents of B. x buttiana extracts with antioxidant and cytotoxic activities using different solvents. The extraction solvents used were as follows: distilled water (dH₂O), methanol (MeOH), acetone (DMK), ethanol (EtOH), ethyl acetate (EtOAc), dichloromethane (DCM), and hexane (Hex) (100%) at an extraction temperature of 26 °C. Analysis of bioactive compounds present in the B. x buttiana extracts included the application of common phytochemical screening assays, GC-MS analysis, and cytotoxicity and antioxidant assays. The results show that the highest extraction yield was observed with water and methanol. The maximum total phenolic content amount and highest antioxidant potential were obtained when extraction with methanol was used. With the exceptions of water and ethanol extractions, all other extracts showed cytotoxicity ranging between 31% and 50%. The prevailing compounds in water, methanol, ethanol, and acetone solvents were as follows: 4H-pyran-4-one, 2,3-dihydro-3, 5-dihydroxy-6-methyl (2), 2-propenoic acid, 3-(2-hydrophenyl)-(E)- (3), and 3-O-methyl-d-glucose (6). By contrast, the major components in the experiments using solvents such as EtOH, DMK, EtOAc, DCM, and Hex were n-hexadecanoic acid (8), 9,12-octadecadienoic acid (Z,Z) (12); 9-octadecenoic acid (E)- (13), and stigmasta-5,22-dien-3-ol (28).Entities:
Keywords: Bougainvillea x buttiana; antioxidant; cytotoxic; solvent extraction; total phenolic content (TPC)
Year: 2016 PMID: 27918436 PMCID: PMC5187543 DOI: 10.3390/antiox5040045
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Polarity index (Snyder [27]).
| Solvent | Polarity Index (PI) |
|---|---|
| Water (dH2O) | 9.0 |
| Methanol (MeOH) | 6.6 |
| Ethanol (EtOH) | 5.2 |
| Acetone (DMK) | 5.1 |
| Ethyl acetate (EtOAc) | 4.4 |
| Dichloromethane (DCM) | 3.7 |
| Hexane (Hex) | 0 |
Figure 1Percent extraction yield. Preparations of B. x buttiana with seven different extraction solvents at 100% at 26 °C for 24 h were prepared as described in the Materials and Methods section. Each bar corresponds to the results (mean ± standard deviation (SD)) from three different preparations.
Figure 2Effect of extraction solvents on the total phenolic content (TPC) amount. Samples of B. x buttiana extracts with solvents at 100% at 26 °C for 24 h were assayed to determine the total phenolic content, as described in the Materials and Methods section. Each bar corresponds to the results (mean ± SD) from three different preparations.
Figure 3Cytotoxicity. B. x buttiana extracts with solvents at 100% at 26 °C for 24, 48 and 72 h were assayed to determine their effects on cellular cytotoxicity, as described in the Materials and Methods section. Each point corresponds to the results (mean ± SD) from three different preparations.
IC50 μg/mL values.
| Solvents | IC50 (µg/mL) |
|---|---|
| dH2O | 286.80 ± 0.01 |
| MeOH | 223.10 ± 0.02 |
| EtOH | 232.10 ± 0.02 |
| DMK | 300.90 ± 0.05 |
| EtOAc | 353.80 ± 0.01 |
| DCM | 1455.68 ± 0.19 |
| Hex | 373.70 ± 0.03 |
Compounds present in different solvent extracts.
| N° | Compounds | RT (min) | Solvent‘s | ||||||
|---|---|---|---|---|---|---|---|---|---|
| dH2O | MeOH | EtOH | DMK | EtOAc | DCM | Hex | |||
| GC Area % | |||||||||
| 1 | 2,5-Dimethyl-4-hydroxy-3(2H)-furanone | 8.20 | 0.87 | ||||||
| 2 | 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- | 9.55 | 0.48 | 0.62 | |||||
| 3 | 2-Propenoic acid, 3-(2-hydrophenyl)-(E)- | 10.61 | 2.57 | 2.75 | 2.11 | ||||
| 4 | Ethanone, 1-(2-hydroxy-5-methylphenyl)- | 12.04 | 0.51 | ||||||
| 5 | Phenol, 2,4-bis(1,1-dimethylethyl)- | 14.57 | 9.88 | ||||||
| 6 | 3- | 17.19 | 96.01 | 94.17 | 51.44 | 16.80 | |||
| 7 | Tetradecanoic acid | 17.38 | 1.92 | ||||||
| 8 | n-Hexadecanoic acid | 19.49 | 10.76 | 23.10 | 12.40 | 4.14 | 26.50 | ||
| 9 | Hexadecanoic acid, ethyl ester | 19.8 | 1.96 | ||||||
| 10 | Naphthalene, 3,4-dihydro-1,8-bis (trimethylsilyloxy)- | 19.99 | 8.94 | ||||||
| 11 | 2-(Phenyl-piperidin-1-yl-methyl)-cyclohexanol | 21.16 | 0.86 | ||||||
| 12 | 9,12-Octadecadienoic acid (Z,Z)- | 21.16 | 6.35 | 19.90 | 14.05 | 3.37 | |||
| 13 | 9-Octadecenoic acid (E)- | 21.21 | 10.40 | 10.64 | |||||
| 14 | Octadecanoic acid | 21.35 | 1.35 | 1.32 | 5.29 | ||||
| 15 | 9,12-Octadecadienoic acid, ethyl ester | 21.39 | 0.90 | 2.95 | |||||
| 16 | 9,12,15-Octadecatrienoic acid, ethyl ester, (Z,Z,Z)- | 21.46 | 2.93 | ||||||
| 17 | Pentacosane | 24.88 | 1.49 | ||||||
| 18 | Heptacosane | 28.16 | 2.56 | 2.50 | |||||
| 19 | Oxirane, heptadecyl- | 30.04 | 2.93 | ||||||
| 20 | Hexacosane, 9-octyl- | 30.33 | 2.42 | 1.86 | |||||
| 21 | Nonacosane | 30.76 | 5.33 | 7.61 | |||||
| 22 | 1,30-Triacontanediol | 32.56 | 4.45 | 11.30 | 14.47 | ||||
| 23 | 1-Dotriacontanol | 33.46 | 19.90 | 16.07 | 18.07 | ||||
| 24 | 1-Hexacosene | 33.59 | 29.87 | ||||||
| 25 | Vitamin E | 34.18 | 2.93 | ||||||
| 26 | Cyclooctacosane | 35.34 | 4.36 | ||||||
| 27 | 1-Triacontanol | 37.34 | 10.39 | 22.21 | |||||
| 28 | Stigmasta-5,22-dien-3-ol | 37.34 | 7.72 | 10.60 | 4.63 | 2.53 | 25.81 | ||
| 29 | Chondrillasterol | 37.55 | 1.02 | 8.98 | |||||
| 30 | Stigmast-7-en-3-ol, (3β,5α) | 38.86 | 9.62 | ||||||
Figure 4Structures of the compounds.